Search Results for Social Media

Showing 1 – 25  of 49

FDA Enforcement Trends for Broadcast Advertisements By Justin Mann, Julie Tibbets - Published 28 September 2017

This article presents recent FDA enforcement trends related to broadcast advertisements and explains how regulatory professionals can approach the review and approval of promotional materials. The article also provides a review of relevant FDA authorities and guidance, as well as practical takeaways for industry with a focus on product ads appearing on TV or YouTube that may distract viewers from important risk information.

Categories: Features, US, FDA, Advertising and Promotion, Drugs

Tags: Office of Prescription Drug Promotion, OPDP, Warning Letter, YouTube, Social Media

Asia Regulatory Roundup: Vietnam Drug Agency Adds Aurobindo, Other Indian Drugmakers to Blacklist (15 November 2016) By Nick Paul Taylor - Published 15 November 2016

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, MHLW, TGA, Biologics and biotechnology, Drugs, Labeling, Medical Devices, Regulatory intelligence, Regulatory strategy

Tags: drug advertising, social media and pharmaceuticals, Aurobindo Pharma

European Regulatory Roundup: Lead Brexiteer Dismisses Need for UK to Stay in EU Regulatory System (10 November 2016) By Nick Paul Taylor - Published 10 November 2016

Welcome to our European Regulatory Roundup, our weekly overview of the top EU regulatory news.

Categories: News, EC, EMA, MHRA, Biologics and biotechnology, Drugs, Ethics, Government affairs, Medical Devices

Tags: Brexit, Big Data, regulatory science, social media, adverse event reporting

Drug Marketing on Twitter: FDA to Study Space-Limited Communications By Michael Mezher - Published 07 November 2016

The US Food and Drug Administration (FDA) is planning to study whether links can be sufficient means of presenting risk information about drugs in advertising on social media platforms, such as Twitter, where character space is limited.

Categories: News, US, FDA, Advertising and Promotion, Communication, Prescription drugs

Tags: Social media, Twitter, Google

The Importance of Internal Systems to Support Social Media Campaigns By Kelli L. Tanzella, PhD - Published 04 October 2016

This article discusses the importance of internal systems to ensure social media and marketing campaigns are in compliance with FDA requirements.

Categories: Features, US, FDA, Advertising and Promotion

Tags: Social Media

Using Social Media to Promote FDA-Regulated Products - A Balanced Approach is Best By Elizabeth Heredia - Published 22 April 2016

This article shares some of the current thinking on best practice uses of social media in promoting FDA-regulated products.

Categories: Features, FDA, Advertising and Promotion, Communication, Drugs

Tags: Social media

Pharmaceutical Marketing via Social Media By Sofina Jain, RAC - Published 12 January 2016

This article discusses the ongoing effort by the pharmaceutical industry to use social media as a marketing tool. It presents benefits and limitations of using this form of media and describes recent progress in public communication.

Categories: Features, US, FDA, Advertising and Promotion, Communication, Drugs

Tags: Social Media, IMS Health Social Media Engagement Index

FDA to its Scientists: Feel Free to Engage on Social Media By Zachary Brennan - Published 18 November 2015

The US Food and Drug Administration (FDA) is now encouraging employees to use social media in a personal capacity, particularly for sharing information that may benefit public health, as long as employees make clear that their opinions aren’t the views of the agency.

Categories: News, US, FDA, Biologics and biotechnology, Compliance, Drugs, Regulatory intelligence, Submission and registration

Tags: FDA, social media, FDA scientists, government social media policy, Twitter, Facebook

Walking the Digital Tight-Rope By Linda Pollitz, Moulakshi Roychowdhury, PharmD, JD - Published 05 November 2015

On behalf of the Regulatory Focus Board of Editors, we would like to introduce you to a collection of articles on the regulatory oversight of advertising, labeling and social media.

Categories: Under RAPS, China, US, FDA, Advertising and Promotion, Communication, Drugs

Tags: Social media guidance, Office of Prescription Drug Promotion, OPDP, Regulatory Focus

FDA Social Media Guidance–Lessons Learned from the Comment Period By Linda Pollitz, RAC - Published 04 November 2015

This article reviews and summarizes public comments on FDA's two draft social media guidance documents.

Categories: Features, US, FDA, Advertising and Promotion, Communication, Drugs, Regulatory strategy

Tags: Social media guidance, Character space limitations, Twitter

Social Media: Changing the Rules for Regulatory Professionals By Kelli L. Tanzella, PhD - Published 01 October 2015

This article discusses social media's role in the changing regulatory landscape and how regulatory professionals must evolve to ensure compliance with FDA requirements specific to the medical device field.

Categories: Features, US, FDA, Advertising and Promotion, Drugs, Medical Devices, Regulatory strategy

Tags: Social media, Facebook, Twitter, LinkedIn

The Evolving Approach of Presenting Risk Information to Consumers By Richard Lem, PharmD - Published 25 September 2015

This article discusses an evolving approach to present prescription drug risk information to consumers based on recent guidances released by the Agency.

Categories: Features, US, FDA, Advertising and Promotion, Compliance, Drugs, Government affairs, Medical Devices

Tags: Office of Prescription Drug Promotion, FDA, draft guidance, social media, drug ads on social media

Experts to Offer Ad, Promo and Labeling Advice at RAPS Virtual Event By Zachary Brousseau - Published 29 May 2015

As the Internet and social media have become increasingly powerful forces in our everyday lives and important sources of information on personal healthcare decisions, regulators, marketers and healthcare companies all have had to contend with a slew of new challenges. RAPS’ virtual event Advertising, Promotion and Labeling: the US Regulated Environment will bring together experts to offer their advice.

Categories: HTML, Articles, Under RAPS, RAPS Events, US, FDA, FTC, RAPS, Advertising and Promotion, Compliance, Labeling

Tags: advertising, promotion, labeling, social media, social media regulation, FDA, FTC

Free the Tweets: Group Asks FDA to Allow its Scientists to Use Social Media By Alexander Gaffney, RAC - Published 19 March 2015

The US Food and Drug Administration currently lacks any policy permitting its employees to discuss scientific issues on social media channels like Twitter and Facebook, a new report by the scientific advocacy group Union of Concerned Scientists (UCS) has found.

Categories: News, US, FDA

Tags: Twitter, Social Media, FDA Social Media, Report, Union of Concerned Scientists

FDA Cracks Down on Facebook Marketing With Four New Letters to Companies By Alexander Gaffney, RAC - Published 04 March 2015

The US Food and Drug Administration (FDA) is increasingly paying attention to social media, and in particular Facebook, as companies use the social networking platform to market their products.

Categories: News, US, FDA, Advertising and Promotion, Nutritional and dietary supplements

Tags: Facebook, FDA Regulation of Social Media, FDA Social Media, Warning Letter

UK Regulator Releases Advertising Report, Complaints Down 32% from 2013 By Michael Mezher - Published 25 February 2015

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has released its annual report on drug advertising. The agency says complaints are down versus previous years, but notes it received more complaints about advertisements made on websites and social media.

Categories: News, Europe, MHRA, Advertising and Promotion, Over the counter drugs, Prescription drugs, Government affairs

Tags: Advertising and Promotion, Social Media

Singapore Regulator Alleges Fake Lab Report Used on Facebook Page By Michael Mezher - Published 09 January 2015

Singapore’s healthcare product regulator, the Health Sciences Authority (HSA), is alleging that a Malaysian dietary supplement company used falsified lab reports when promoting one of its products on its Facebook page and blog.

Categories: News, Asia, Advertising and Promotion, Nutritional and dietary supplements, Postmarket surveillance

Tags: HSA, Health Sciences Authority, Facebook, Social Media, Singapore, Lab Report

In First, FDA Sends Warning Letters to Companies Citing Use of Pinterest By Alexander Gaffney, RAC - Published 24 September 2014

The US Food and Drug Administration's (FDA) long history of Warning Letters marked a new milestone today after regulators chided three companies, including one which marketed its product on a medium never before cited by FDA: Pinterest.

Categories: News, US, CDER, Drugs, Labeling

Tags: Pinterest, FDA Social Media, Warning Letter

Using Twitter as a Regulatory Intelligence Tool: 460 Accounts Worth Following By Alexander Gaffney, RAC - Published 23 July 2014

How can regulatory professionals use Twitter as a tool to collect regulatory intelligence? This articles explains the basics of Twitter, as well as 460 accounts that life science professionals can follow to get started and make the most out of the social media platform.

Categories: News, Regulatory intelligence

Tags: Healthcare Social Media, Twitter, Social Media, Top Twitter Accounts, Top Twitter in Life Science, Top Twitter in Pharma, Top Twitter in Medical Device, Top Twitter in Biotech

FDA Guidance Says Companies Have Broad Leeway to Correct Misinformation By Alexander Gaffney, RAC - Published 17 June 2014

The US Food and Drug Administration (FDA) has released a new draft guidance document on social media focused on how companies can correct blatant misinformation contained on the Internet and social media channels, long a source of frustration for FDA-regulated companies.

Categories: News, US, FDA, Biologics and biotechnology, Drugs, Labeling, Medical Devices

Tags: Draft Guidance, Social Media, Social Media Guidance, Wikipedia, Guidance, Misinformation, Correcting Misinformation

FDA Guidance: How Can Pharma and Device Companies Use Twitter? Not Easily. By Alexander Gaffney, RAC - Published 17 June 2014

The US Food and Drug Administration (FDA) today released two guidance documents focused on the use of social media by members of regulated industry, including one on how companies can use the social media platform Twitter and other space-limited platforms.

Categories: News, US, FDA, Biologics and biotechnology, Drugs, Labeling, Medical Devices

Tags: Twitter, Google, Tweets, Social Media Guidance, Guidance, Draft Guidance, Character Space Limitations

Industry Sees Much not to ‘Like’ in FDA's First Social Media Guidance Document By Alexander Gaffney, RAC - Published 16 April 2014

Categories: US, FDA

Tags: Social Media Guidance, Facebook, Twitter, Latest News, draft guidance, social media

Once Again, FDA Seeks to Leverage Social Media to Uncover Adverse Events and Public Sentiment By Alexander Gaffney, RAC - Published 26 February 2014

Categories: US, FDA

Tags: social media

FDA Says Many Social Media Guidances on the Way, but Claims FDASIA Deadline has Already Been Met By Alexander Gaffney, RAC - Published 14 January 2014

Categories: US, FDA

Tags: Social Media Guidance, OPDP, FDASIA, Latest News, social media

FDA Releases (its Other) Social Media Guidance By Alexander Gaffney, RAC - Published 13 January 2014

Categories: US, FDA, CDER

Tags: OPDP, Latest News, marketing, draft guidance, advertising, promotion, social media